AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Matthew Frieman

Matthew Frieman

University of Maryland Baltimore - Baltimore / United States
Others
AD Scientific Index ID: 1290300
University of Maryland, Baltimore
person_outline Matthew Frieman's MOST POPULAR ARTICLES
1-) Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine New england journal of medicine 383 (24), 2320-2332, 2020
2-) Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail Science 369 (6506), 1010-1014, 2020
3-) Animal models for COVID-19 Nature 586 (7830), 509-515, 2020
4-) Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles ACS nano 14 (6), 7617-7627, 2020
5-) Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists Journal of virology 81 (2), 548-557, 2007